Rheumatic and bone medications

Rheumatic med items punish calendar mistakes: weekly methotrexate, upright bisphosphonates, and knowing allopurinol is prevention, not a flare extinguisher.

Gout, NSAIDs, muscle relaxants

Gout flares are crystal-driven inflammation in a joint. The joint hurts because leukocytes are attacking urate crystals - so the acute job is anti-inflammatory control (NSAID, colchicine, or steroid as ordered), not dropping the serum uric acid number that day. Allopurinol blocks xanthine oxidase and lowers uric acid over time; it prevents the next attack. Offering only allopurinol while the joint is on fire treats the calendar, not the inflammation.

Colchicine works by blunting neutrophil activity in the inflamed joint. The toxicity that shows up first on the exam is severe GI upset - especially diarrhea - because the therapeutic window is narrow and dose limits are not optional. NSAIDs ease pain and inflammation but irritate gastric mucosa and reduce renal prostaglandin support for perfusion, so take with food and flag GI bleed risk, kidney disease, and interacting drugs.

Baclofen is a centrally acting muscle relaxant. Abrupt stop removes that central suppression suddenly - withdrawal can mean rebound spasticity, agitation, and seizure risk. If the drug needs to come off, taper with a plan; “just hold it today” without a taper order is the distractor that looks cautious and is not.

Edge case that flips the allopurinol answer: a client already on chronic allopurinol who develops a flare is usually not told to stop prevention cold as the only move - treat the flare and clarify the uric-acid plan with the provider. The classic wrong answer is starting allopurinol alone as acute rescue. Diet teaching (lower-purine choices, alcohol limits as ordered) supports prevention; it does not replace anti-inflammatory treatment of an active attack.

DMARDs and biologics

Rheumatoid disease damages joints through ongoing immune activation. DMARDs and biologics slow that process - they are disease modifiers, not PRN pain pills. Methotrexate is the exam favorite because the schedule error is lethal: antirheumatic dosing is usually weekly. Daily dosing is an oncology-style mix-up that can cause severe marrow and mucosal toxicity. Folate as ordered, LFT/CBC monitoring, and pregnancy avoidance exist because the drug hits rapidly dividing cells and is teratogenic.

• Methotrexate: weekly schedule, lab monitoring, folate, contraception/pregnancy avoidance, infection vigilance.
• Report mouth ulcers, fever, unexplained bruising, or severe fatigue.

Mouth sores, fever, bruising, or crushing fatigue are not “expected RA days” on methotrexate - they can signal toxicity or infection while the marrow and mucosa are suppressed. Hold and notify when those cues appear; do not coach the client to push through another weekly dose without clarification. The distractor that looks thorough is filling a daily pill organizer for MTX “so they won’t forget” - that rebuilds the lethal schedule.

TNF inhibitors (for example etanercept) block a cytokine that helps contain mycobacteria and other pathogens. That is why latent TB screening and treating active infection before start are safety gates, not paperwork. A new fever or productive cough on a biologic is hold-and-workup territory - infection can accelerate when the TNF brake is off.

Hydroxychloroquine is a DMARD that needs ophthalmology on the calendar: retinal toxicity is uncommon but vision change is a report-now cue, and baseline/periodic eye exams are standard teaching. Other DMARDs (sulfasalazine, leflunomide patterns as tested) share infection vigilance and lab monitoring themes - yellow skin, severe diarrhea, or unexplained bruising still means call, not “push through arthritis week.”

Bisphosphonates

Oral bisphosphonates (alendronate and related agents) slow osteoclast bone resorption, which is why they appear in osteoporosis teaching. The pill itself is caustic to esophageal mucosa if it sits there - absorption also collapses if food, coffee, or other meds share the stomach window. The upright, empty-stomach, full-water ritual is esophageal protection plus absorption, not fussiness.

1. Take first thing on an empty stomach with a full glass of plain water.
2. Remain upright for 30–60 minutes (follow the specific drug’s instruction).
3. Do not eat, drink other fluids, or take other meds in that window.
4. Report new heartburn, dysphagia, or jaw pain as directed.

At the bedside: give it first thing, plain water only, then keep the client sitting or standing for the labeled interval. Lying down for a “quick nap” after the dose is the classic fail - reflux brings the tablet against the esophagus. Juice, coffee, calcium, or other pills in that window look like ordinary morning habits and still break the rule.

New heartburn or dysphagia after dosing can mean esophageal irritation - stop and report rather than repeating the dose and lying flat. Jaw pain is a rarer osteonecrosis teaching point: report as directed; do not dismiss it as dental trivia when the client is on chronic bisphosphonate therapy. Timing windows differ slightly by product - teach the drug in hand, not a memorized minute count that ignores the label. Calcium and vitamin D often ride along for bone health, but oral calcium in the same empty-stomach window sabotages bisphosphonate absorption - separate them. Probenecid (uricosuric) teaching includes avoiding salicylate interference with its effect when stems raise aspirin use.

Priority map